Literature DB >> 9243078

The role of cytokines in disease progression in heart failure.

K Shan1, K Kurrelmeyer, Y Seta, F Wang, Z Dibbs, A Deswal, D Lee-Jackson, D L Mann.   

Abstract

Recent studies have identified the importance of biologically active molecules such as neurohormones as mediators of disease progression in heart failure. More recently it has become apparent that in addition to neurohormones, another portfolio of biologically active molecules, termed cytokines, are also expressed in the setting of heart failure. This article reviews recent clinical and experimental material that suggests that the cytokines, much like the neurohormones, may represent another class of biologically active molecules that are responsible for the development and progression of heart failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243078     DOI: 10.1097/00001573-199705000-00002

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  12 in total

1.  Increasing cardiac contractility after myocardial infarction exacerbates cardiac injury and pump dysfunction.

Authors:  Hongyu Zhang; Xiongwen Chen; Erhe Gao; Scott M MacDonnell; Wei Wang; Mikhail Kolpakov; Hiroyuki Nakayama; Xiaoying Zhang; Naser Jaleel; David M Harris; Yingxin Li; Mingxin Tang; Remus Berretta; Annarosa Leri; Jan Kajstura; Abdelkarim Sabri; Walter J Koch; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

2.  Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.

Authors:  D J Brull; J Sanders; A Rumley; G D Lowe; S E Humphries; H E Montgomery
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 3.  Endothelin in heart failure.

Authors:  G Sütsch; M Barton
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

4.  Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.

Authors:  Luiza Guilherme; Patricia Cury; Lea M F Demarchi; Verônica Coelho; Lúcia Abel; Ana P Lopez; Sandra Emiko Oshiro; Selma Aliotti; Edécio Cunha-Neto; Pablo M A Pomerantzeff; Ana C Tanaka; Jorge Kalil
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 5.  Biology of TNFalpha and IL-10, and their imbalance in heart failure.

Authors:  Kuljeet Kaur; Sanjiv Dhingra; Jan Slezak; Anita K Sharma; Anju Bajaj; Pawan K Singal
Journal:  Heart Fail Rev       Date:  2008-08-19       Impact factor: 4.214

6.  Biomarker profile in stable Fontan patients.

Authors:  Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book
Journal:  Int J Cardiol       Date:  2020-01-09       Impact factor: 4.164

Review 7.  Cholinergic activity as a new target in diseases of the heart.

Authors:  Ashbeel Roy; Silvia Guatimosim; Vania F Prado; Robert Gros; Marco A M Prado
Journal:  Mol Med       Date:  2015-01-26       Impact factor: 6.354

Review 8.  MicroRNA involvement in immune activation during heart failure.

Authors:  Mathijs van de Vrie; Stephane Heymans; Blanche Schroen
Journal:  Cardiovasc Drugs Ther       Date:  2011-04       Impact factor: 3.727

Review 9.  Molecular and cellular mechanisms of cardiotoxicity.

Authors:  Y J Kang
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

Review 10.  Morphological aspects of apoptosis in heart diseases.

Authors:  Genzou Takemura; Hisayoshi Fujiwara
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.